Progressive Multiple Sclerosis Completed Phase 2 Trials for Methylprednisolone (DB00959)

Also known as: Progressive multiple sclerosis

IndicationStatusPhase
DBCOND0051688 (Progressive Multiple Sclerosis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01305837Cyclic Oral Methylprednisolone Trial in Multiple SclerosisTreatment